Simplex Trading’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-34,700
| Closed | -$4.45M | – | 9085 |
|
|
2025
Q2 | $4.45M | Buy |
34,700
+27,900
| +410% | +$2.9M | ﹤0.01% | 1447 |
|
|
2025
Q1 | $601K | Sell |
6,800
-7,600
| -53% | -$741K | ﹤0.01% | 3196 |
|
|
2024
Q4 | $1.25M | Sell |
14,400
-22,300
| -61% | -$2.04M | ﹤0.01% | 2626 |
|
|
2024
Q3 | $3.39M | Buy |
36,700
+4,500
| +14% | +$447K | ﹤0.01% | 1824 |
|
|
2024
Q2 | $3.47M | Sell |
32,200
-5,900
| -15% | -$591K | ﹤0.01% | 1703 |
|
|
2024
Q1 | $3.61M | Buy |
38,100
+2,600
| +7% | +$223K | ﹤0.01% | 1870 |
|
|
2023
Q4 | $3.27M | Sell |
35,500
-3,100
| -8% | -$201K | ﹤0.01% | 1917 |
|
|
2023
Q3 | $1.94M | Buy |
38,600
+5,100
| +15% | +$273K | ﹤0.01% | 2101 |
|
|
2023
Q2 | $2.12M | Buy |
33,500
+20,300
| +154% | +$1.1M | ﹤0.01% | 1935 |
|
|
2023
Q1 | $593K | Buy |
13,200
+8,600
| +187% | +$387K | ﹤0.01% | 3098 |
|
|
2022
Q4 | $201K | Buy |
4,600
+2,500
| +119% | +$120K | ﹤0.01% | 4216 |
|
|
2022
Q3 | $138K | Buy |
2,100
+2,000
| +2,000% | +$128K | ﹤0.01% | 5076 |
|
|
2022
Q2 | $5K | Sell |
100
-10,900
| -99% | -$639K | ﹤0.01% | 8793 |
|
|
2022
Q1 | $702K | Buy |
11,000
+10,500
| +2,100% | +$754K | ﹤0.01% | 3394 |
|
|
2021
Q4 | $53K | Sell |
500
-2,400
| -83% | -$251K | ﹤0.01% | 7182 |
|
|
2021
Q3 | $254K | Hold |
2,900
| – | – | ﹤0.01% | 5198 |
|
|
2021
Q2 | $255K | Buy |
2,900
+2,895
| +57,900% | +$265K | ﹤0.01% | 5267 |
|
|
2021
Q1 | $48K | Buy |
+5
| New | +$499 | ﹤0.01% | 6660 |
|
|
2020
Q2 | – | Sell |
-145
| Closed | -$847K | – | 7621 |
|
|
2020
Q1 | $847K | Sell |
145
-12
| -8% | -$772 | ﹤0.01% | 2034 |
|
|
2019
Q4 | $1.26M | Buy |
157
+109
| +227% | +$8.16K | ﹤0.01% | 1884 |
|
|
2019
Q3 | $352K | Sell |
48
-15
| -24% | -$1.3K | ﹤0.01% | 2998 |
|
|
2019
Q2 | $594K | Buy |
63
+33
| +110% | +$2.72K | ﹤0.01% | 2408 |
|
|
2019
Q1 | $240K | Sell |
30
-34
| -53% | -$2.51K | ﹤0.01% | 3403 |
|
|
2018
Q4 | $345K | Sell |
64
-62
| -49% | -$3.77K | ﹤0.01% | 2579 |
|
|
2018
Q3 | $983K | Sell |
126
-107
| -46% | -$7.44K | ﹤0.01% | 1906 |
|
|
2018
Q2 | $1.48M | Buy |
233
+166
| +248% | +$13.2K | 0.01% | 1400 |
|
|
2018
Q1 | $16K | Buy |
67
+23
| +52% | +$1.98K | ﹤0.01% | 3551 |
|
|
2017
Q4 | $1K | Sell |
44
-13
| -23% | -$915 | ﹤0.01% | 5432 |
|
|
2017
Q3 | $3K | Buy |
+57
| New | +$3.05K | ﹤0.01% | 4733 |
|
|
2017
Q2 | – | Sell |
-96
| Closed | -$45K | – | 6104 |
|
|
2017
Q1 | $45K | Buy |
+96
| New | +$3.44K | ﹤0.01% | 2465 |
|
|
2016
Q4 | – | Sell |
-100
| Closed | -$4K | – | 5850 |
|
|
2016
Q3 | $4K | Buy |
+100
| New | +$2.48K | ﹤0.01% | 4418 |
|
Other funds holding BPMC
IA
HNB
Simplex Trading's BPMC Position: Q3 2025 in Review
Simplex Trading sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 55,989 shares — an estimated $7.18M sold.
Simplex Trading first reported a position in BPMC in Q3 2015 and held it in 21 quarters. The position peaked at $7.18M in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- Simplex Trading reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- Simplex Trading sold 55,989 Blueprint Medicines shares in Q3 2025, an estimated $7.18M.
- Simplex Trading first reported a position in Blueprint Medicines in Q3 2015 and held it in 21 quarters.
- Simplex Trading's Blueprint Medicines position peaked at $7.18M in Q2 2025.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.